SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001753926-24-000569
Filing Date
2024-03-19
Accepted
2024-03-19 18:18:21
Documents
1
Period of Report
2024-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 ownership.html 4  
1 FORM 4 ownership.xml 4 3738
  Complete submission text file 0001753926-24-000569.txt   5330
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Issuer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LIPELLA PHARMACEUTICALS INC. 7800 SUSQUEHANNA ST., SUITE 505 PITTSBURGH PA 15208
Business Address
Cohen Daniel R (Reporting) CIK: 0001971611 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41575 | Film No.: 24765469